First International Workshop in Clinical Pharmacology in HIV Therapy, 30-31 March 2000, Noordwijk, Netherlands
Simon Collins, HIV i-Base
The First International Workshop in Clinical Pharmacology in HIV Therapy was held from 30-31 March in Noordwijk, the Netherlands.
Over 30 oral presentations and 50 posters provided information on new assays, quality assurance, drug interactions, adherence, sanctuary sites, PK related to efficacy and therapeutic drug levels monitoring.
It was notable that over 40 of the 120 delegates present were from the US, and this reflected an increased interest in using TDM in clinical practice that has been generated by European researchers.
Reports in this issue:
- TDM: standardisation and quality control
- TDM for individualising dosing – practicality and efficacy for PIs and RTIs
- TDM and adherence
- Drug interactions: amprenavir, saquinavir, ABT-378/r (lopinavir/r), indinavir, efavirenz, ritonavir
- L-Acetyl Carnitine (LAC) improves symptoms of peripheral neuropathy (PN): evidence for increases in cutaneous innervation